Changeflow GovPing Drug Safety Safety Concerns Over Imported Counterfeit Melat...
Priority review Notice Added Final

Safety Concerns Over Imported Counterfeit Melatonin Products

Favicon for www.tga.gov.au TGA Australia Safety Alerts
Published January 29th, 2026
Detected March 12th, 2026
Email

Summary

The Therapeutic Goods Administration (TGA) has issued a safety advisory regarding imported counterfeit unregistered melatonin products. Laboratory testing revealed significant discrepancies in melatonin content, with some products containing over 400% of the labelled amount and others none at all, posing serious risks to consumers, especially children.

What changed

The Therapeutic Goods Administration (TGA) has issued a safety advisory concerning imported counterfeit unregistered melatonin products. Laboratory testing confirmed that several products do not meet Australian standards, with actual melatonin content varying drastically from labelled amounts. Some products contained significantly more melatonin than indicated (up to 417%), while others contained none. These discrepancies pose serious safety risks, including accidental overdose and hospitalization, particularly for children.

Consumers are advised that melatonin is generally a prescription-only medicine in Australia. The TGA urges consumers to check for an AUST R or AUST L number on product packaging to ensure products meet Australian safety, quality, and effectiveness standards. This advisory highlights the risks associated with purchasing unregistered therapeutic goods online or from local retailers and emphasizes the importance of choosing regulated medicines.

What to do next

  1. Verify that any melatonin products intended for import or sale in Australia are listed on the Australian Register of Therapeutic Goods (ARTG) with an AUST R or AUST L number.
  2. Educate consumers about the risks of unregistered therapeutic goods and the importance of checking for ARTG listing.
  3. Review import and supply chains to ensure compliance with Australian therapeutic goods regulations.

Source document (simplified)

Safety concerns over imported counterfeit melatonin products

Safety advisory Published

29 January 2026

  • Listen
  • Print
  • Share
    • LinkedIn
    • (Twitter)
    • Facebook
    • Email On this page: The Therapeutic Goods Administration (TGA) is issuing an updated safety advisory regarding imported counterfeit unregistered melatonin products.

Test results

Laboratory testing of several imported unregistered melatonin products has confirmed they are counterfeit under the Therapeutic Goods Act 1989.

The results indicate significant discrepancies in the actual melatonin content compared to the labelled amounts. One product contained more than 400% of the labelled content and another containing no melatonin at all. See the summary report for information on all the samples tested.

This variability in melatonin content raises serious safety concerns for consumers, including the risk of accidental overdose and hospitalisation, especially in children.

The following products contained significantly more than the labelled amount:

| Product | Variation from labelled amount |
| --- | --- |
| Spring Valley Extra Strength Melatonin 10mg tablets | 119%-136% |
| Natrol Melatonin 5mg gummies Strawberry Flavour | 140%-170% |
| CVS Health Melatonin 3mg tablets | 112%-121% |
| The Smurfs Kids Gummies Melatonin 1mg | 155%-170% |
| Natrol Advanced Sleep Melatonin 10mg Time Release tablets | 112%-123% |
| Sleepose-3 Melatonin 3mg tablets | 209%-417% |
| Vitafusion Sleep Well - Melatonin 3mg tablets | 106%-124% |
The following products contained significantly less than the labelled amount:

| Product | Variation from labelled amount |
| --- | --- |
| Life Extension Melatonin 300mcg Vegetarian capsules | 79%-97% |
| Sleepose-10 Melatonin 10mg tablets | 37%-59% |
| Live Nature’s Melatonin 10mg capsules | No melatonin detected |
| Sanofi Novanuit Triple Action 1mg Melatonin + plant extracts tablets | 76%-99% |

Why choose regulated medicines

The products tested by TGA Laboratories are known as unregistered therapeutic goods. These products can often be purchased online or from local retailers, however, they may not meet Australian standards for safety, quality and effectiveness.

To check if a product is on the Australian Register of Therapeutic Goods (ARTG), look for an AUST R or AUST L number on the packaging. This number confirms that the medicine meets Australian standards, including:

Information for consumers

  • Melatonin is a prescription-only medicine in Australia, except in specific circumstances for adults.
  • Parents are strongly encouraged to consult their child’s treating medical practitioner regarding the use of melatonin, especially for children with seizure disorders as it may increase seizure frequency.
  • Melatonin products taken without appropriate medical oversight can cause serious side effects including accidental overdose and hospitalisation, especially in children.
  • Even with a valid prescription, counterfeit products cannot be imported into Australia under the Personal Importation Scheme.
  • Importing, supplying and/or giving away counterfeit therapeutic goods is illegal and poses a significant public health and safety risk.
  • Stop using unregistered melatonin products immediately and take any remaining items to your local pharmacy for safe disposal.
  • If you have any concerns arising from the use of these or similar products, seek advice from your treating medical practitioner.
  • If you suspect you or someone you care for has had a side effect (also known as an adverse event) to this or a similar medicine, report it to the TGA.
  • If you are considering purchasing medicines from overseas watch this short video on the risks associated with buying medicines and medical devices online. We advise consumers to exercise extreme caution when purchasing medicines from unknown overseas websites.

Products purchased over the internet:

  • may be fake
  • may contain incorrect or undisclosed and harmful ingredients.
  • may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia. For your safety, always buy medicines from reputable sources, check for an AUST R or AUST L number, and consult your healthcare provider or local registered pharmacy if you have any questions.

Information for health professionals

Doctors may choose to prescribe melatonin to their patients ‘off-label’. 'Off-label use' is a clinical decision made at the discretion of the treating clinician who is responsible for obtaining informed consent from their patient and ensuring that the medicine is the appropriate treatment option and carries a positive benefit–risk profile.

The TGA does not regulate clinical practice or off-label use.

Health professionals also play a key role in identifying and managing the risks associated with unregistered melatonin products and should advise patients accordingly.

Health professionals are encouraged to report adverse events involving medicines, including unapproved medicines. These reports assist the TGA in identifying previously unknown side effects and other safety issues.

Action we are taking

The TGA continues to monitor signals relating to harmful unregistered products and will notify the Australian Border Force (ABF) to seize and destroy any counterfeit products intercepted at the border.

Reporting problems

If you experience an adverse event you are encouraged to report it to the TGA as this helps us monitor and respond to emerging safety concerns.

If you suspect non-compliance in relation to therapeutic goods, you can report a perceived breach or questionable practice online to the TGA.

| Phone: | 1800 020 653 |
| Online: | Report a problem or side effect |
| Email: | info@tga.gov.au |

Product images

Topics
- Import and export
- Safety monitoring and information
Product types
- Over-the-counter medicines
- Prescription medicines
- Unapproved therapeutic goods

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
Various
Published
January 29th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Consumers Food manufacturers Importers and exporters Manufacturers
Geographic scope
Australia

Taxonomy

Primary area
Product Safety
Operational domain
Compliance
Topics
Pharmaceuticals Consumer Protection Import/Export

Get Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when TGA Australia Safety Alerts publishes new changes.

Free. Unsubscribe anytime.